Association between traditional cardiovascular risk factors and mortality in the oldest old: untangling the role of frailty

Cardiovascular disease in Europe: epidemiological update 2016

(2016) Nick Townsend et al.   EUROPEAN HEART JOURNAL

No evidence that frailty modifies the positive impact of antihypertensive treatment in very elderly people: an investigation of the impact of frailty upon treatment effect in the HYpertension in the Very Elderly Trial (HYVET) study, a double-blind, placebo-controlled study of antihypertensives in people with hypertension aged 80 and over

(2015) Jane Warwick et al.   BMC Medicine

The burden of disease in older people and implications for health policy and practice

(2015) Martin J Prince et al.   LANCET

Relation between blood pressure and mortality risk in an older population: role of chronological and biological age

(2014) G. Post Hospers et al.   JOURNAL OF INTERNAL MEDICINE

Treatment of Hypertension in the Oldest Old

(2013) Majon Muller et al.   HYPERTENSION

NT-proBNP Best Predictor of Cardiovascular Events and Cardiovascular Mortality in Secondary Prevention in Very Old Age: The Leiden 85-Plus Study

(2013) Petra G. van Peet et al.   PLoS One

Prognostic value of cardiovascular disease status: the Leiden 85-plus study

(2012) Petra G. van Peet et al.   AGE

Rethinking the Association of High Blood Pressure With Mortality in Elderly Adults

(2012) Michelle C. Odden et al.   ARCHIVES OF INTERNAL MEDICINE

Secondary Prevention of Stroke in the Elderly: A Review of the Evidence

(2011) Ahmed Alhusban et al.   American Journal Geriatric Pharmacotherapy

Treatment of hypertension in patients 80 years and older: the lower the better? A meta-analysis of randomized controlled trials

(2010) Theodora Bejan-Angoulvant et al.   JOURNAL OF HYPERTENSION

The BELFRAIL (BFC80+) study: a population-based prospective cohort study of the very elderly in Belgium

(2010) Bert Vaes et al.   BMC Geriatrics